Amyris (FRA:3A01) ROCE % : -232.93% (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

What is Amyris ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Amyris's annualized ROCE % for the quarter that ended in Mar. 2023 was -232.93%.

Amyris ROCE % Historical Data

The historical data trend for Amyris's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amyris ROCE % Chart

Amyris Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-926.26

-66.68

-95.21

Amyris Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
ROCE %	Get a 7-Day Free Trial															-64.65	-68.76	-127.52	-126.20	-232.93

Amyris ROCE % Calculation

Amyris's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-485.114	/	( ( (844.554 - 238.777)	+	(778.736 - 365.467) )	/ 2 )
	=	-485.114	/	( (605.777	+	413.269)	/ 2 )
	=	-485.114	/	509.523
	=	-95.21 %

Amyris's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	-708.544	/	( ( (778.736 - 365.467)	+	(634.82 - 439.722) )	/ 2 )
	=	-708.544	/	( ( 413.269	+	195.098 )	/ 2 )
	=	-708.544	/	304.1835
	=	-232.93 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2023) EBIT data.

Amyris (FRA:3A01) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Amyris ROCE % Related Terms

Thank you for viewing the detailed overview of Amyris's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Amyris (FRA:3A01) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Amyris Inc (FRA:3A01) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

AMRSQ:USA

Address

5885 Hollis Street, Suite 100, Emeryville, CA, USA, 94608

Website

https://www.amyris.com

Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.

Amyris (FRA:3A01) Headlines

No Headlines